Monthly Archives: October 2012

BIO Investor Forum: The New Kids on the Biotech Block

desert

Where should biotech start-ups look for funding in the venture capital desert that is becoming the new normal? The panel The New Kids on the Biotech Block: Trends in Early-Stage Financing kicked off the 11th Annual BIO Investor Forum and focused on non-traditional early-stage investors and deal structures. Moderated by Jeron Eaves, a senior practice executive with Campbell Alliance, the panel highlighted companies that have secured financing from creative sources, like patient advocacy groups and venture Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

34 daily newspapers from California urge voters to vote NO on Prop 37

No-on-Prop-37

In recent editorials, California’s major daily newspapers are urging voters to reject Proposition 37 on the November ballot.  Read all No on Prop. 37 editorials here. The San Jose Mercury News says Prop 37 has best of intent, but bad drafting. “Proposition 37 should never have been placed on the ballot this fall.”  “…there are real problems with this particular law.” “A badly drafted law with good intentions is still a bad law.” “Voters should reject Read More >

Farmer Gene  |  2 Comments  |  Email This Post
Tags: , , , , , ,

BIO Technology Transfer Symposium: Funding that First $2 Million

2-mill

With creative funding schemes picking up steam and nontraditional funders taking an interest in biotech, what can universities and start-ups expect in their right first-round financing structure? At the BIO Technology Transfer Symposium, a panel examined various funding sources as well as the factors that influence investment decisions and the ins and outs of early stage financing deals. William Tucker, executive director, Innovation Alliances and Services, University of California Office of the President, moderated a Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Cancer Stem Cell Therapy: Real Or Just Hype?

Stem Cell Therapy

Also known as tumor-initiating cells, cancer stem cells (CSC) have unique capability endemic to stem cells of self-renewal and differentiation, thereby causing tumor relapse and/or metastatis. While traditional cancer treatments focus on tumor shrinkage, it’s a distinct possibility that these agents do not effectively destroy all of the CSCs, causing the tumor to reappear. The CSC theory is relatively new, so the treatment pipeline is still in its early stages. Nathan Sadeghi-Nejad, a contributor to Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Take the Pledge, Support FuelsAmerica

FuelsAmerica

Fuels America is a new coalition of groups and individuals who have a stake in the success of biofuels. The coalition is founded on a simple core principle: Renewable fuel is good for the U.S. economy, for our nation’s energy security and for the environment.  BIO is a founding member of the coalition and along with others we ask that you join the fight by visiting the website and pledging support for the Renewable Fuel Read More >

Environmental & Industrial  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,